Rhenman & Partners Asset Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-19,500
Closed -$2.43M – 99
2025
Q2
$2.43M Buy
19,500
+15,000
+333% +$1.91M 0.31% 66
2025
Q1
$573K Sell
4,500
-4,500
-50% -$693K 0.07% 93
2024
Q4
$1.3M Sell
9,000
-1,000
-10% -$143K 0.13% 87
2024
Q3
$1.49M Hold
10,000
– – 0.12% 90
2024
Q2
$1.26M Buy
10,000
+5,000
+100% +$784K 0.12% 88
2024
Q1
$920K Sell
5,000
-5,000
-50% -$952K 0.09% 84
2023
Q4
$1.8M Buy
+10,000
New +$1.56M 0.18% 75

Other funds holding RGEN

Rhenman & Partners Asset Management's RGEN Position: Q3 2025 in Review

Rhenman & Partners Asset Management sold out of Repligen (RGEN) in Q3 2025, closing a stake of 19,500 shares — an estimated $2.43M sold.

Rhenman & Partners Asset Management first reported a position in RGEN in Q4 2023 and held it in 7 quarters. The position peaked at $2.43M in Q2 2025. 453 funds tracked by Wall St. Rank hold RGEN as of Q3 2025.

  • Rhenman & Partners Asset Management reported no remaining Repligen position as of Q3 2025 after selling out during the quarter.
  • Rhenman & Partners Asset Management sold 19,500 Repligen shares in Q3 2025, an estimated $2.43M.
  • Rhenman & Partners Asset Management first reported a position in Repligen in Q4 2023 and held it in 7 quarters.
  • Rhenman & Partners Asset Management's Repligen position peaked at $2.43M in Q2 2025.
  • 453 funds tracked by Wall St. Rank held Repligen as of Q3 2025.

Based on Rhenman & Partners Asset Management's 13F filing for Q3 2025, filed 13 Nov 2025.